Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.

Shelly MA, Jacoby H, Riley GJ, Graves BT, Pichichero M, Treanor JJ.

Infect Immun. 1997 Jan;65(1):242-7.

2.

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

O'Brien KL, Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Madore D.

Pediatr Infect Dis J. 1996 May;15(5):425-30.

PMID:
8724065
3.

Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults.

Rubins JB, Puri AK, Loch J, Charboneau D, MacDonald R, Opstad N, Janoff EN.

J Infect Dis. 1998 Aug;178(2):431-40.

PMID:
9697723
4.

Antibody titers eight months after three doses of a five-valent pneumococcal conjugate vaccine in HIV and non-HIV-infected children less than two years of age.

King JC Jr, Vink PE, Chang I, Kimura A, Parks M, Smilie M, Lichenstein R, Farley JJ.

Vaccine. 1998 Feb;16(4):361-5.

PMID:
9607056
5.

Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.

Manoff SB, Liss C, Caulfield MJ, Marchese RD, Silber J, Boslego J, Romero-Steiner S, Rajam G, Glass NE, Whitney CG, Carlone GM.

J Infect Dis. 2010 Feb 15;201(4):525-33. doi: 10.1086/651131.

PMID:
20088694
6.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.

de Roux A, Schmöle-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM.

Clin Infect Dis. 2008 Apr 1;46(7):1015-23. doi: 10.1086/529142. Erratum in: Clin Infect Dis. 2008 May 1;46(9):1488. Schmöele-Thoma, B [corrected to Schmöle-Thoma, B].

PMID:
18444818
7.
8.
9.

Advances in pneumococcal vaccines: what are the advantages for the elderly?

Vila-Córcoles A.

Drugs Aging. 2007;24(10):791-800. Review.

PMID:
17896829
10.
11.

Pneumococcal polysaccharide immunization in infants and children.

Cowan MJ, Ammann AJ, Wara DW, Howie VM, Schultz L, Doyle N, Kaplan M.

Pediatrics. 1978 Nov;62(5):721-7.

PMID:
31592
12.
13.

Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.

Reinert P, Benkerrou M, de Montalembert M, Lesprit E, Abadie I, Bernaudin F, Doit C, Bingen E, Tetelboum R, Bonnet E.

Pediatr Infect Dis J. 2007 Dec;26(12):1105-9.

PMID:
18043446
14.

IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.

Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H; ARIVAC Consortium.

Vaccine. 2009 May 5;27(20):2680-8. doi: 10.1016/j.vaccine.2009.02.059. Epub 2009 Feb 24.

PMID:
19428879
15.

Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.

Hilleman MR, Carlson AJ Jr, McLean AA, Vella PP, Weibel RE, Woodhour AF.

Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S31-42. Review.

PMID:
7025159
16.

Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination.

Mufson MA, Hughey DF, Turner CE, Schiffman G.

Vaccine. 1991 Jun;9(6):403-7.

PMID:
1887670
17.

Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study.

Jackson LA, Baxter R, Naleway AL, Belongia EA, Baggs J.

BMC Infect Dis. 2009 Mar 25;9:37. doi: 10.1186/1471-2334-9-37.

18.

Does the 23-valent pneumococcal vaccine protect cochlear implant recipients?

Hey C, Rose MA, Kujumdshiev S, Gstoettner W, Schubert R, Zielen S.

Laryngoscope. 2005 Sep;115(9):1586-90.

PMID:
16148699
19.

Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults.

Wuorimaa T, Käyhty H, Leroy O, Eskola J.

Vaccine. 2001 Feb 28;19(15-16):1863-9.

PMID:
11228355

Supplemental Content

Support Center